Johnson & Johnson (JNJ)
207.03
+0.12
(+0.06%)
USD |
NYSE |
Dec 31, 16:00
206.98
-0.05
(-0.02%)
After-Hours: 19:50
Johnson & Johnson Cash from Investing (Quarterly): -542.00M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -414.00M |
| Gilead Sciences, Inc. | -427.00M |
| Eli Lilly & Co. | -2.983B |
| Regeneron Pharmaceuticals, Inc. | -402.90M |
| Protagonist Therapeutics, Inc. | -58.56M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 9.169B |
| Cash from Financing (Quarterly) | -8.927B |
| Free Cash Flow | 20.46B |
| Free Cash Flow Per Share (Quarterly) | 3.292 |
| Free Cash Flow to Equity (Quarterly) | 12.96B |
| Free Cash Flow to Firm (Quarterly) | 8.255B |
| Free Cash Flow Yield | 4.08% |